Related Experiment Video
Updated: May 15, 2026

Assessment of Vascular Function in Patients With Chronic Kidney Disease
Published on: June 16, 2014
Chronic kidney disease as a coronary artery disease risk equivalent
Alexandrios Briasoulis1, George L Bakris
1ASH Comprehensive Hypertension Center, Department of Medicine, The University of Chicago Medicine, 5841 S. Maryland Avenue, Chicago, IL 60637, USA.
Insights
Chronic kidney disease (CKD) significantly elevates cardiovascular disease (CVD) risk, making it a major cause of death. Early evaluation for kidney disease is crucial for patients at risk of coronary artery disease (CAD).
Area of Science:
- Nephrology and Cardiology
- Public Health and Epidemiology
Background:
- Chronic kidney disease (CKD) is strongly linked to increased cardiovascular disease (CVD) risk and mortality.
- Patients with advanced CKD (stages 3-5) and those on dialysis face a higher risk of all-cause and cardiovascular death.
- Cardiovascular disease (CVD) is the leading cause of death in CKD patients, surpassing end-stage kidney disease progression.
Purpose of the Study:
- To highlight the independent role of CKD as a cardiovascular disease (CVD) risk factor.
- To emphasize the heightened risk of coronary artery disease (CAD) in individuals with declining kidney function.
- To advocate for integrated screening and management of cardiovascular and kidney health.
Main Methods:
- Review of prospective cohort studies and existing data on CKD and CVD.
- Analysis of mortality rates and risk factors in CKD populations.
- Epidemiological assessment of the relationship between kidney function and cardiovascular events.
Main Results:
- Coronary artery disease (CAD) risk escalates exponentially with CKD progression (stage 3 and higher).
- Over 50% of deaths in CKD patients are attributed to CVD.
- CKD is recognized as an independent CVD risk factor and a CAD equivalent for mortality.
Conclusions:
- CKD significantly accelerates cardiovascular disease (CVD) risk, necessitating proactive management.
- All individuals at risk for coronary artery disease (CAD) should be screened for kidney disease.
- Therapeutic strategies for established CAD may offer comparable benefits to CKD patients.
Abstract:
Chronic kidney disease (CKD) is associated with accelerated cardiovascular disease (CVD) risk and a higher CVD event rate. Substantial data from prospective cohort studies support the concept that dialysis patients as well as those with advanced stage (stages 3-5) CKD are associated with an increased risk for all-cause and cardiovascular mortality. The risk for coronary artery disease (CAD) increases exponentially with declining kidney function, i.e., stage 3 or higher CKD. Indeed, CVD accounts for more than 50 % of deaths in patients with CKD. CKD patients are more likely to die of CVD than to progress to end stage kidney disease. This increase in CV risk is commonly attributed to co-existence of numerous traditional and nontraditional risk factors for the development of CVD that frequently accompany reduced kidney function. Therefore, CKD itself is now considered an independent CVD risk factor and a coronary artery disease (CAD) equivalent for all-cause mortality. All patients at risk for CAD should be evaluated for kidney disease. Treatments used for management of established CAD might have similar benefits for patients with concomitant CKD.
Related Concept Videos
Chronic Kidney Disease I: Introduction
Chronic Kidney Disease II: Clinical Manifestations
Coronary Artery Disease I: Introduction
Chronic Kidney Disease III: Interprofessional Care
Chronic Kidney Disease IV: Nursing Management
Coronary Artery Disease IV: Preventive Measures
